CSMD1 rs10503253 increases schizophrenia risk in a Tunisian population-group

The Complement System in the Central Nervous System: From Neurodevelopment to Neurodegeneration

(2022) Ying Chen et al.   Biomolecules

Genetic polymorphisms of 17 X-STR loci in two Tunisian populations from Sousse and Makthar

(2022) Abir Mejri et al.   ANNALS OF HUMAN BIOLOGY

Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice

(2020) Melis Yilmaz et al.   NATURE NEUROSCIENCE

The complement system in schizophrenia: where are we now and what’s next?

(2019) Julia J. Woo et al.   MOLECULAR PSYCHIATRY

The HLA 8.1 Ancestral Haplotype in schizophrenia: dual implication in neuro‐synaptic pruning and autoimmunity?

(2019) Ryad Tamouza et al.   ACTA PSYCHIATRICA SCANDINAVICA

Cognitive Deficits in Schizophrenia: Understanding the Biological Correlates and Remediation Strategies

(2018) Adarsh Tripathi et al.   Clinical Psychopharmacology and Neuroscience

Replicated association between the European GWAS locus rs10503253 at CSMD1 and schizophrenia in Asian population

(2017) Weiqing Liu et al.   NEUROSCIENCE LETTERS

No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population

(2016) Yansong Liu et al.   BMC Psychiatry

Schizophrenia risk from complex variation of complement component 4

(2016) Aswin Sekar et al.   NATURE

Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1

(2014) Wei Xu et al.   BMC Medical Genetics

Biological insights from 108 schizophrenia-associated genetic loci

(2014)   NATURE

The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males

(2014) Erasmia Koiliari et al.   SCHIZOPHRENIA RESEARCH

Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders

(2014) Holly N Cukier et al.   Molecular Autism

Neural effects of theCSMD1genome-wide associated schizophrenia risk variant rs10503253

(2013) Emma J. Rose et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly

(2013) Astrid Escudero-Esparza et al.   FASEB JOURNAL

Neuropsychological effects of theCSMD1genome-wide associated schizophrenia risk variant rs10503253

(2013) G. Donohoe et al.   GENES BRAIN AND BEHAVIOR

Neuropsychological Deficits in Mice Depleted of the Schizophrenia Susceptibility Gene CSMD1

(2013) Vidar M. Steen et al.   PLoS One

Genome-wide association study identifies five new schizophrenia loci

(2011)   NATURE GENETICS

Cancer and the Complement Cascade

(2010) M. J. Rutkowski et al.   MOLECULAR CANCER RESEARCH

Common variants conferring risk of schizophrenia

(2009) Hreinn Stefansson et al.   NATURE